Literature DB >> 8531848

Solitary focal demyelination in the brain as a paraneoplastic disorder.

J H Jaster1, T E Bertorini, F C Dohan, T F O'Brien, H Wang, T Becske, P G Menke, C R Handorf, L H Horner, K E Mönkemüller.   

Abstract

Solitary focal demyelination (SFD) in the brain is an uncommon and poorly understood disorder of uncertain etiology that may represent an intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis. In a few reported cases of SFD, the patient was briefly noted to have a nonneurological malignancy. We studied two patients who had solitary focal lesions in the brain. Utilizing magnetic resonance imaging and tissue biopsy, we found the characteristics of the brain lesions in these two patients to be those of SFD. In our combined experience over the past 10 years, we have encountered no similar brain lesions at our medical center. We found it remarkable that both of these patients also had malignancy outside of the nervous system. One had a seminoma, and the other a lymphoma. We conclude that some cases of SFD in the brain may occur as a paraneoplastic disorder associated with nonneurological malignancies.

Entities:  

Mesh:

Year:  1996        PMID: 8531848     DOI: 10.1002/(SICI)1096-911X(199602)26:2<111::AID-MPO8>3.0.CO;2-O

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

Review 1.  Small cell lung carcinoma presenting with acute disseminated encephalomyelitis.

Authors:  R Summerfield; A Al-Saleh; S E Robbins
Journal:  Br J Radiol       Date:  2010-03       Impact factor: 3.039

Review 2.  Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature.

Authors:  Marcos C B Oliveira; Marcelo H de Brito; Mateus M Simabukuro
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

3.  Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma.

Authors:  Wataru Shiraishi; Takeru Umemura; Yuuki Nakayama; Yui Yamada; Masahiro Shijo; Tetsuya Hashimoto
Journal:  Front Neurol       Date:  2022-07-11       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.